Concurrent administration of the erythromycin breath test (EBT) and oral midazolam as in vivo probes for CYP3A activity

Journal of Clinical Pharmacology

Volumn 39, Issue 12, 1999, Pages 1212-1220

  McCrea, J ^a   Prueksaritanont, T ^a   Gertz, B J ^a   Carides, A ^a   Gillen, L ^a   Antonello, S ^a   Brucker, M J ^a   Miller Stein, C ^a   Osborne, B ^a   Waldman, S ^a  

^a MERCK RESEARCH LABORATORIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARBON DIOXIDE; CYTOCHROME P450 3A; ERYTHROMYCIN; KETOCONAZOLE; MIDAZOLAM;

ADULT; AREA UNDER THE CURVE; ARTICLE; BREATH ANALYSIS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DROWSINESS; DRUG METABOLISM; DRUG TOLERABILITY; ENZYME ACTIVITY; HUMAN; HUMAN EXPERIMENT; MALE; NORMAL HUMAN; RANDOMIZED CONTROLLED TRIAL; REPRODUCIBILITY;

EID: 0033309227     PISSN: 00912700     EISSN: None     Source Type: Journal    
DOI: 10.1177/00912709922012015     Document Type: Article

References (20)

1. Noninvasive tests of CYP3A enzymes
2. Cytochrome P4503A and the dapsone recovery ratio: Lack of inhibition by ketoconazole
3. Absence of correlations among three putative in vivo probes of human cytochrome P4503A activity in young healthy men
4. Comparison of urinary 6-β-cortisol and the erythromycin breath test as measures of hepatic P450IIIA (CYP3A) activity
5. Terfenadine-ketoconazole interaction
6. The erythromycin breath test selectively measures P450IIIA in patients with severe liver disease
7. Erythromycin breath test as an assay of glucocorticoid-inducible liver cytochromes P450
8. Grapefruit juice increases felodipine oral availability in humans by decreasing intestinal CYP3A protein expression
9. Grapefruit juice greatly increases the serum concentrations of lovastatin and lovastatin acid
10. Oral first-pass elimination of midazolam involves both gastrointestinal and hepatic CYP3A-mediated metabolism
11. Midazolam should be avoided in patients receiving the systemic antimycotics ketoconazole and itraconazole
12. Use of midazolam as human cytochrome P450 3A probe: 1 In vitro-in vivo correlations in liver transplant patients
13. The erythromycin breath test predicts the clearance of midazolam
14. A potentially hazardous interaction between erythromycin and midazolam
15. Breath tests as noninvasive assay of P450s
16. 14C N-methyl] erythromycin breath test in healthy male volunteers
17. Predicting drug interactions in vivo from experiments in vitro: Human studies with paclitaxel and ketoconazole
18. The effect of estrogen replacement therapy on CYP3A activity